Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
This report contains market size and forecasts of Cancer Hormone Therapy Drugs in Global, including the following market information:
Global Cancer Hormone Therapy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Hormone Therapy Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tamoxifen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Hormone Therapy Drugs include Roche, Amgen, Pfizer, Teva, Takeda, Samyang Biopharmaceuticals, Tolmar, AstraZeneca and Novartis and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Hormone Therapy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Hormone Therapy Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Hormone Therapy Drugs Market Segment Percentages, by Type, 2021 (%)
Tamoxifen
Aromatase Inhibitors
Antiandrogens
Androgen Synthesis Inhibitors
Other
Global Cancer Hormone Therapy Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Hormone Therapy Drugs Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Prostate Cancer
Global Cancer Hormone Therapy Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Hormone Therapy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Hormone Therapy Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Hormone Therapy Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
Pfizer
Teva
Takeda
Samyang Biopharmaceuticals
Tolmar
AstraZeneca
Novartis
Aspen